Doing More With Less: Saol Hopes To Evade New SL1009 Trial With Range Of New Analyses

 
• By Bridget Silverman
  
Ultra-rare pediatric rare diseases like PDC deficiency cannot support new clinical trials to address NDA deficiencies, Saol will tell the FDA. (Shutterstock)

More from Rare Diseases

More from Pink Sheet